Satyajit Kumar Mitra

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Palo Alto, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Satyajit Kumar Mitra
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Satyajit Kumar Mitra

Form 4 holding Executive Director, Head of Oncology

Peak Bio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
31,700
Estimated value
Report date
01 Nov 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Satyajit Kumar Mitra

3

Peak Bio, Inc.

Report period
01 Nov 2022
Transactions
0
Transaction value
$0
Accepted by SEC
03 Nov 2022, 21:49
Role
Executive Director, Head of Oncology Exhibit 24 - Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .